Biotechnology and pharmaceutical companies near Vancouver, British Columbia
The following biotechnology and pharmaceutical companies are among the many Vancouver, British Columbia and area companies listed in the BC Contacts Directory.Kenneth Galbraith, Chairman and Interim Chief Executive Officer
AnorMED Inc.
200 - 20353 64th Avenue
Langley, BC V2Y 1N5
Tel. 604 530-1057
Fax. 604 530-0976
info AT anormed.com
www.anormed.com
Galbraith has almost 20 years of experience in the biotechnology sector, including serving as Executive Vice- President and Chief Financial Officer for QLT Inc. until October 2000. Mr. Galbraith was elected to the Board of AnorMED in April 2006.
Chris Springate, President, Co-Founder and Director
ARC Pharmaceuticals
102 - 2386 East Mall
Vancouver, BC V6T 1Z3
Tel: 604 222-9577
Fax: 604 222-9578
cspringate AT arcpharma.com
IR AT arcpharma.com
info AT arcpharma.com
www.arcpharma.com
Richard Glickman, Co-founder, Chairman and Chief Executive Officer
Aspreva Pharmaceuticals Corporation
1203 - 4464 Markham Street
Victoria, BC V8Z 7X8
Tel. 250 744-2488
Fax. 250 744-2498
info AT aspreva.com
Careers AT aspreva.com
www.aspreva.com
In co-founding Aspreva, Mr. Glickman is building on past successes founding major companies including Stressgen Biotechnologies Corp. As Co-founder and CEO he directed the growth of Stressgen from a small startup to a major biotechnology player with a market capitalization over $500 million. He oversaw the development team that took the lead compound (HspE7) through IND to Phase II clinical trials and orphan drug designation. Stressgen subsequently partnered HspE7 with F. Hoffmann-La Roche
Mr. Glickman comes to Aspreva with a solid track record of success in raising significant capital in this industry, and strong business development skills including the ability to build high quality executive management teams, and forge successful partnerships.
Prior to Stressgen, Mr. Glickman was the founder and director of Ontario Molecular Diagnostics, a diagnostic facility that evolved into the largest molecular diagnostic laboratory in Canada. He also co-founded Probtec Corporation, a rational drug design and molecular genetics firm, where, as Vice-president of Corporate Development, he established and introduced the first licensed DNA-based forensic and paternity testing services into Canada. Mr. Glickman received both Canada’s and British Columbia’s Top 40 under 40 Awards for entrepreneurs.
Mr. Glickman has been chair or member of various biotechnology boards, the BC Biotechnology Alliance and the federal Biotechnology Advisory Committee. He is a former director of the Canadian Genetic Diseases Network.
Doug Buchanan, President and Chief Executive Officer
BC Biomedical Laboratories Ltd.
7455 130th Street
Surrey, BC V3W 1H8
Tel. 604 507-5000
Fax. 604 507-5200
info AT bcbiomedical.com
www.bcbio.com
Ms. Karimah Es Sabar, Executive Director
B.C. Biotechnology Alliance Society
900 - 1188 West Georgia Street
Vancouver, BC V6E 4A2
Tel: 604 602-5225 - direct
Tel. 604 669-9909 - general
Fax: 604 602-9912
kessabar AT bcbiotech.ca
www.bcbiotech.ca
Karimah Es Sabar has had a dynamic career in the healthcare industry globally since 1982, having worked on five continents with business associations in over 60 countries. Ms. Es Sabar has held senior management positions with international multinational companies, most notably as Director International Division, and later Director Marketing & Business Development at Connaught Laboratories Limited [now Aventis Pasteur] based in Toronto.
Amongst her achievements, the company received the Gold Canada Award for Business Excellence in 1992 for the International Division’s marketing success in Europe; and she very successfully project managed the company's first biotherapeutic from development to launch worldwide.
More recently Ms. Es Sabar was Vice President and Chief Operating Officer for a North Vancouver medical devices company. She was also the founder and Managing Director of SAL Healthcare Limited, a leading healthcare organization in Kenya specializing in pharmaceutical marketing, distribution and healthcare consulting services. The company set new standards in the marketing and distribution of healthcare products in the region.
Ms.Es Sabar holds BSc. Joint Honours degree in Biochemistry/Chemistry from the University of Salford, England, and a MSc. degree in Neurochemistry from the Institute of Psychiatry, University of London, England.
Robert Mackie, Chief Executive Officer
BioLytical Laboratories Inc.
1108 - 13351 Commerce Parkway
Richmond, BC V6V 2X7
Tel. 604 204-6784
Fax. 604 244-8399
www.biolytical.com
Mr. Mackie is president and CEO of bioLytical™ Laboratories Inc. His career in business spans more than 20 years; providing leadership and expertise to a number of companies. Mr. Mackie is experienced in import/export, business-to-business transactions, corporate takeover and restructuring, and marketing strategy.
He was co-founder and owner of one of the largest mobile communications companies in Western Canada. For more then 10 years he has successfully managed land and commercial real estate within an international portfolio.
As CEO his demonstrated leadership skills and ability to motivate will give bioLytical™ the edge in moving forward. Born and raised in British Columbia, Mr. Mackie is actively involved in a number of charitable organizations as well as fund raising for community sports and youth educational programs. He is an active contributor to the INSTI™ Foundation both at home and abroad.
Barry Allen, President
British Columbia Medical Device Industry Association
101 - 1099 West 8th Avenue
Vancouver, BC V6H 1C3
Tel 604 878-8718
Fax: 604 878-8717
info AT bcmediabc.com
bcmedia AT bcmediabc.com
www.bcmediabc.com
Barry Allen is also President and CEO, VSM Medtech Ltd.
Marnie Mitchell, Chief Executive Officer
British Columbia Pharmacy Association
Suite 1530 - 1200 West 73rd Avenue
Vancouver, BC V6P 6G5
Tel 604 261-2092
Fax: 604 261-2097
Marnie.Mitchell AT bcpharmacy.ca
info AT bcpharmacy.ca
www.bcpharmacy.ca
Don Enns, President, Chief Executive Officer and Board Member
Cantest Ltd.
4606 Canada Way - Burnaby Life Sciences Centre
Burnaby, BC V5G 1K5
Tel 604 734 - 7276
Fax: 604 731 - 2386
denns AT cantest.com
cantest AT cantest.com
www.cantest.com
Doug Janzen, President, Chief Business Officer & Director
Cardiome Pharma Corp
600 - 6190 Agronomy Road
Vancouver, BC V6T 1Z3
Tel. 604 677-6905
Fax. 604 677-6915
DJanzen AT cardiome.com
admin AT cardiome.com
www.cardiome.com
Janzen leads management of all of Cardiome's business activities, including capital markets, commercial development, partnering, licensing and strategic transactions.
Janzen joined Cardiome in January of 2003, and has extensive experience in corporate banking and financing within the biotech sector. Prior to joining Cardiome, Mr. Janzen served as Managing Director, Health Sciences and Partner at Sprott Securities Inc., a Toronto-based investment bank.
Dr. Andrew Janoff, Chairman and Chief Executive Officer
Celator Pharmaceuticals Corp.
200 - 604 West Broadway
Vancouver, BC V5Z 1G1
Tel. 604 708-5858
Fax. 604 708-5883
info AT celatorpharma.com
www.celatorpharma.com
Jeffery Ho,
Centre for Drug Research and Development
103 - 6190 Agronomy Road
Vancouver, BC V6T 1Z3
Tel. 604 827-5015
Fax.
jho AT cdrd.ca
www.cdrd.ca
Dr. Hassan Salari, Chairman, President & Chief Executive Officer
Chemokine Therapeutics Corp.
405 - 6190 Agronomy Road
Vancouver, BC V6T 1Z3
Tel. 604 822-0304 - direct
Tel. 604 822-0301
Fax. 604 822-0302
salari AT chemokine.net
www.chemokine.net
Salari is experienced in managing private and public biotechnology companies. Prior to his engagement at Chemokine Therapeutics Corp., Dr. Salari founded and built the biotech company, Inflazyme Pharmaceuticals Ltd (IZP.TO).
From 1992 to 1998 he had, in his role as President and Chief Executive Officer, the responsibility of managing the company's business affairs as well as its drug discovery and development program. He negotiated and closed several licensing deals with biotechnology and pharmaceutical companies.
Alistair Duncan, President, Chief Executive Officer and Director
Chromos Molecular Systems Inc.
8081 Lougheed Highway
Burnaby, BC V5A 1W9
Tel. 604 415-7100
Fax. 604 415-7151
ADuncan AT chromos.com
info AT chromos.com
www.chromos.com
Ron Evans, M.E.Sc., C.C.E., P.Eng., President
Datrend Systems Inc.
1 - 3531 Jacombs Road
Richmond, BC V6V 1Z8
Tel. 604 291-7747
Fax. 604 294-2355
customerservice AT datrend.com
www.datrend.com
Eric Adams, President, Chief Executive Officer and Director
enGene Inc.
100 - 2386 East Mall
Vancouver, BC V6T 1Z3
Tel. 604 221-4362
Fax. 604 221-4369
EAdams AT engeneinc.com
info AT engeneinc.com
www.engeneinc.com
Dr. John Nestor, Chief Scientific Officer
Forbes Medi-Tech Inc.
200 - 750 West Pender Street
Vancouver, BC V6C 2T8
Tel. 604 689-5899
Fax. 604 689-7641
JNestor AT forbesmedi.com
info AT forbesmedi.com
www.forbesmedi.com
Dr. Nestor's responsibilities encompass both the advancement of the technology that he developed under TheraPei as well as the optimization of Forbes' existing FM-VPx pipeline.
Before founding TheraPei, Nestor served as Executive Vice President, Drug Discovery at Sequenom; Vice President & Director at the Institute of Bio-organic Chemistry, Syntex; and Distinguished Scientist at Roche Bioscience.
Dr. Nestor is an inventor of 10 compounds selected for clinical development and the lead inventor on 3 currently marketed pharmaceuticals. He is co-inventor on more than 45 U.S. Patents, author of more than 60 scientific articles, Editor of 2 books, and Associate Editor, Letters in Drug Design and Discovery.
Recently, he was an invited Chapter Author for Comprehensive Medicinal Chemistry II (Elsevier, 2006), contributing "Peptide and Protein Drugs: Issues and Solutions". Dr. Nestor has more than 25 years of leadership experience in drug discovery/development programs in major pharma and biotech.
Dr. June Wong, Vice President and Director
Genetrack Biolabs Inc. (Genex Diagnostics Inc.)
401 - 1508 West Broadway
Vancouver, BC V6J 1W8
Tel. 604 325-7282
Fax. 604 325-2208
lab AT genetrack.bc.ca
www.genetrack.bc.ca
James DeGreef, Co-Founder and President
GenoLogics Life Sciences Software Inc.
2305 - 4464 Markham Street
Victoria, BC V8Z 7X8
Tel. 1 866 457-5467 - Toll Free
Tel. 1 250 483-7011
Fax: 1 250 483-3201
james AT genologics.com
sales AT genologics.com
info AT genologics.com
hr AT genologics.com
www.genologics.com
Alan Winter, President and Chief Executive Officer
Genome British Columbia
500 - 555 West 8th Avenue
Vancouver, BC V5Z 1C6
Tel 604 738.8072
Fax: 604 738.8597
awinter AT genomebc.ca
info AT genomebc.ca
www.genomebc.ca
Gil Geere, Laboratory Manager
I.G. Micromed Environmental Inc.
190 - 12860 Clarke Place
Richmond, BC V6V 2H1
Tel. 604 279-0666
Fax. 604 279-0663
ggeere AT igmicromed.com
info AT igmicromed.com
www.igmicromed.com
Dr. Santa Ono, Chief Scientific Officer
iCo Therapeutics Inc.
760 - 777 Hornby Street
Vancouver, BC V6Z 1S4
Tel. 604 602-9414
Fax. 604 602-9699
ono AT icotherapeutics.com
info AT icotherapeutics.com
www.icotherapeutics.com
Professor Ono, a leading authority in the fields of immunology and ophthalmology, joined iCo Therapeutics in July 2005 as Chief Scientific Officer. Professor Ono continues to serve as GlaxoSmithKline Professor of Biomedical Sciences, University College, University of London, and Chair of Immunology, UCL-Institute of Ophthalmology, Moorfields Eye Hospital (the world’s first and largest eye research and treatment centre).
Past appointments include Assistant Professor of Medicine, Pathology & Biology at Johns Hopkins University, and Associate Professor & Director of the Immunity, Inflammation and Transplantation Group at the Schepens Eye Research Institute, Harvard Medical School.
Professor Ono has directed multiple research and development programs, many of which have been in partnership with biotechnology and pharmaceutical companies.
Professor Ono received degrees from the University of Chicago (BA) and McGill University (PhD) and was a Helen Hay Whitney Fellow at Harvard University. He serves on many editorial boards, is involved with numerous professional societies and associations, and has more than eighty publications to his credit.
Todd Patrick, President and Chief Operating Officer
ID Biomedical Corporation
1630 - 200 Burrard Street
Vancouver, BC V6C 3L6
Tel 604 431-9314
Fax 604 431-9378
info AT idbiomedical.com
employment AT idbiomedical.com
www.idbiomedical.com
Timothy Ruane, President and Chief Executive Officer
Inex Pharmaceuticals Corp.
200 - 8900 Glenlyon Parkway
Burnaby, BC V5J 5J8
Tel. 604 419-3200
Fax. 604 419-3201
info AT inexpharm.com
www.inexpharm.com
Timothy Ruane was paid $520,000 in 2005 even though the company was on the verge of bankruptcy and fired 35 employees.
Kevin Mullane, Ph.D., President & Chief Executive Officer
Inflazyme Pharmaceuticals Ltd.
425 - 5600 Parkwood Way
Richmond, BC V6V 2M2
Tel. 604 279-8511
Fax. 604 279-8711
MK AT inflazyme.com
info AT inflazyme.com
www.inflazyme.com
